| ||||||||
| ||||||||
| Site Group Page (References Reporting High Throughput Detection Method) |
| Site Information | ||||||||||||||||||||
|
||||||||||||||||||||
| References | ||
|
Wagner SA, et al. (2012) Proteomic analyses reveal divergent ubiquitylation site patterns in murine tissues. Mol Cell Proteomics 11, 1578-85
22790023 Curated Info |
|
|
Kim W, et al. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 44, 325-40
21906983 Curated Info |
|
|
(2010) CST Curation Set: 10366; Year: 2010; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10260; Year: 2010; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10261; Year: 2010; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10262; Year: 2010; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 10263; Year: 2010; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 9192; Year: 2010; Biosample: U266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2010) CST Curation Set: 8771; Year: 2010; Biosample: AMO-1; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8668; Year: 2009; Biosample: RPMI-8266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8643; Year: 2009; Biosample: U266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8641; Year: 2009; Biosample: U266; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8644; Year: 2009; Biosample: U266; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8639; Year: 2009; Biosample: L363; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8635; Year: 2009; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8637; Year: 2009; Biosample: L363; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8640; Year: 2009; Biosample: L363; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8636; Year: 2009; Biosample: L363; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8630; Year: 2009; Biosample: AMO-1; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8629; Year: 2009; Biosample: AMO-1; Disease: multiple myeloma; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8634; Year: 2009; Biosample: AMO-1; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8631; Year: 2009; Biosample: AMO-1; Disease: multiple myeloma; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK Antibody Used to Purify Peptides prior to MS2: Ubiquitin (D4A7A10) XP(R) Rabbit mAb Cat#: 3925, PTMScan(R) Ubiquitin Branch Motif (K-e-GG) Immunoaffinity Beads Cat#: 1990
Curated Info |
|
|
(2009) CST Curation Set: 8585; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: Geldanamycin; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8586; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: Velcade; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8583; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: AAG; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8581; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: control; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8582; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: AAG; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 8584; Year: 2010; Biosample: PC3; Disease: prostate cancer; Treatment: Geldanamycin; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|
|
(2009) CST Curation Set: 6589; Year: 2009; Biosample: NCI-H929; Disease: multiple myeloma; Treatment: control; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-UbK
Curated Info |
|